1. NAFLD (nonalcoholic fatty liver disease), CVD, and type 2 diabetes: Details of the study design
Targher G et al. Diabetes Care 2007;30:1212-8

2. Baseline characteristics of the study participants, grouped according to NAFLD status
Targher G et al. Diabetes Care 2007;30:1212-8

3. Age- and sex-adjusted prevalence of CVD in type 2 diabetic adults with () and without () NAFLD
Targher G et al. Diabetes Care 2007;30:1212-8

4. Association between NAFLD and prevalent CVD in type 2 diabetic adults with and without NAFLD (n=2.392)
Data are expressed as ORs 95% CI. *The multiple adjustment reported in the third and fourth bars was as follows: age, sex, BMI, smoking status, diabetes duration, A1C, LDL cholesterol, and current use of medications (hypoglycemic, antihypertensive, lipid-lowering, or antiplatelet drugs).
Targher G et al. Diabetes Care 2007;30:1212-8